Home > News > Diversa Granted U.S. Patent
August 11th, 2003
Diversa Granted U.S. Patent
Diversa Corporation (Nasdaq: DVSA) today announced that it has been issued U.S. Patent No. 6,602,675, expanding its proprietary position for identifying biologically active molecules from the environment. The patent is directed to small molecule and enzyme discovery from both cultured and uncultured filamentous fungi and bacteria using high-throughput fluorescent screening. In addition to their utility for discovering novel enzyme products for agricultural and chemical applications, the technologies covered in this patent are an important part of Diversa’s small molecule discovery platform, which includes high-throughput culturing and recombinant expression for developing natural product drug candidates.
Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program November 17th, 2014
First genetic-based tool to detect circulating cancer cells in blood: NanoFlares light up individual cells if breast cancer biomarker is present November 17th, 2014
Ki-Bum Lee Patents Technology To Advance Stem Cell Therapeutics November 13th, 2014
'Direct writing' of diamond patterns from graphite a potential technological leap November 5th, 2014